Skip to main content

Advertisement

Log in

Effects of vitamin E on serum enzymes and electrolytes in hypercholesterolemia

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

It is not known if vitamin E in hyperlipidemia and hypercholesterolemia of longer duration has any beneficial or adverse effects on electrolytes, and liver and kidney function. The objectives of this study are to determine (i) if long duration of mild hypercholesterolemia has any adverse effects on serum electrolytes, glucose and enzymes related to liver and kidney functions; (ii) if vitamin E has any effects on serum electrolytes, glucose and enzymes related to liver and kidney function in hypercholesterolemia. Blood samples were collected from the rabbits before and at various intervals during administration of a high cholesterol diet (0.25%) for 2 and 4 months, and while on a high cholesterol diet with vitamin E following a high cholesterol diet. Measurements of serum total cholesterol (TC), glucose, aspartate aminotransferase (AST), alkaline phosphatase (ALP), alanine aminotransferase (ALT), gamma-glutamyltransferase (GGT), albumin, creatinine, electrolytes [sodium (Na), potassium (K), chloride (Cl), and carbon dioxide (CO2)] were made. High cholesterol diet for 2 months produced hypercholesterolemia which was associated with reductions in serum glucose, unaltered serum electrolytes, ALT, ALP, GGT, albumin and creatinine, and increased levels of AST. Hypercholesterolemia for 4 months had effects similar to hypercholesterolemia for 2 months except it lowered serum ALP. Vitamin E did not affect any of the parameters except serum glucose and Cl, which decreased compared to the values at month 2. Hypercholesterolemia for short and long term does not have adverse effects on liver or kidney function, and serum electrolytes. Vitamin E during hypercholesterolemia does not affect serum electrolytes or liver and kidney function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Rimm B, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC (1993) Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 328:1450–1456

    Article  CAS  PubMed  Google Scholar 

  2. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC (1993) Vitamin E consumption and the risk of coronary heart disease in women. N Engl J Med 328:1444–1449

    Article  CAS  PubMed  Google Scholar 

  3. Kushi LH, Folsom AR, Prineas RJ, Mink PJ, Wu Y, Bostick RM (1996) Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med 334:1156–1162

    Article  CAS  PubMed  Google Scholar 

  4. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ (1996) Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347:781–786

    Article  CAS  PubMed  Google Scholar 

  5. Losonczy KG, Harris TB, Havlik RJ (1996) Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: the Established Population for Epidemiologic Studies of the Elderly. Am J Clin Nutr 64:190–196

    CAS  PubMed  Google Scholar 

  6. GISSI-Prevenzione Investigators (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354:447–455

    Article  Google Scholar 

  7. Heart Protection Study Collaborative Group (2002) MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20, 536 high-risk individuals: a randomized placebo-controlled trial. Lancet 360:23–33

    Article  Google Scholar 

  8. de Gaetano G, Collaborative Group of the Primary Prevention Project (2001) Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomized trial in general practice. Lancet 357:89–95

    Article  PubMed  Google Scholar 

  9. Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P (2000) Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342:154–160

    Article  CAS  PubMed  Google Scholar 

  10. Prasad K, Kalra J (1993) Oxygen free radicals and hypercholesterolemic atherosclerosis: effect of vitamin E. Am Heart J 125:958–973

    Article  CAS  PubMed  Google Scholar 

  11. Negis Y, Aytan N, Özer N, Ogru E, Libinaki R, Gianello R, Azzi A, Zingg JM (2006) The effect of tocopheryl phosphates on atherosclerosis progression in rabbits fed with a high cholesterol diet. Arch Biochem Biophys 450:63–66

    Article  CAS  PubMed  Google Scholar 

  12. Prasad K (2009) Vitamin E does not slow the progression of hypercholesterolemic atherosclerosis. Int J Angiol (in press)

  13. Prasad K (2009) Vitamin E does not regress hypercholesterolemic atherosclerosis. J Cardiovasc Pharmacol Ther (in press)

  14. Prasad K, Kalra J, Lee P (1994) Oxygen free radicals as a mechanism of hypercholesterolemic atherosclerosis: effects of Probucol. Int J Angiol 3:100–112

    Article  Google Scholar 

  15. Prasad K (1999) Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed. Circulation 99:1355–1362

    CAS  PubMed  Google Scholar 

  16. Prasad K, Lee P (2007) Suppression of hypercholesterolemic atherosclerosis by pentoxifylline and its mechanism. Atherosclerosis 192:313–322

    Article  CAS  PubMed  Google Scholar 

  17. Lee P, Prasad K (2003) Suppression of oxidative stress as a mechanism of reduction of hypercholesterolemic atherosclerosis by cyclooxygenase inhibitors. Int J Angiol 12:13–23

    Article  Google Scholar 

  18. Freeman BA, Crapo JD (1982) Biology of disease: free radicals and tissue injury. Lab Invest 47:412–426

    CAS  PubMed  Google Scholar 

  19. Prasad K (2008) Serum biochemical changes in rabbits on a regular diet with and without flax lignan complex following a high cholesterol diet. Int J Angiol 17:27–32

    Google Scholar 

  20. Prasad K (2009) Flax lignan complex slows down the progression of atherosclerosis in hyperlipidemic rabbits. J Cardiovasc Pharmacol Ther 14:38–48

    Article  CAS  PubMed  Google Scholar 

  21. Cyrus T, Yao Y, Rokach J, Tang LX, Praticò D (2003) Vitamin E reduces progression of atherosclerosis in low-density lipoprotein receptor-deficient mice with established vascular lesions. Circulation 107:521–523

    Article  CAS  PubMed  Google Scholar 

  22. Averill MM, Bennett BJ, Rattazzi M, Rodmyre RM, Kirk EA, Schwartz SM, Rosenfeld ME (2009) Neither antioxidants nor genistein inhibit the progression of established atherosclerotic lesions in older apoE deficient mice. Atherosclerosis 203:82–88

    Article  CAS  PubMed  Google Scholar 

  23. Xu G, Stoffers DA, Habener JF, Bonner-Weir S (1999) Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Diabetes 48:2270–2276

    Article  CAS  PubMed  Google Scholar 

  24. Katsuma S, Hirasawa A, Tsujimoto G (2005) Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochem Biophys Res Commun 329:386–390

    Article  CAS  PubMed  Google Scholar 

  25. Haidara MA, Mikhailidis DP, Rateb MA, Ahmed ZA, Yassin HZ, Ibrahim IM, Rashed LA (2009) Evaluation of the effect of oxidative stress and vitamin E supplementation on renal function in rats with streptozotocin-induced Type 1 diabetes. J Diabetes Complicat 23:130–136

    Article  PubMed  Google Scholar 

  26. Yokote K, Bujo H, Hanaoka H, Shinomiya M, Mikami K, Miyashita Y, Nishikawa T, Kodama T, Tada N, Saito Y (2008) Multicenter collaborative randomized parallel group comparative study of pitavastatin and atorvastatin in Japanese hypercholesterolemic patients: collaborative study on hypercholesterolemia drug intervention and their benefits for atherosclerosis prevention (CHIBA study). Atherosclerosis 201:345–352

    Article  CAS  PubMed  Google Scholar 

  27. Assy N, Kaita K, Mymin D, Levy C, Rosser B, Minuk G (2000) Fatty infiltration of liver in hyperlipidemic patients. Dig Dis Sci 45:1929–1934

    Article  CAS  PubMed  Google Scholar 

  28. Lu LS, Wu CC, Hung LM, Chiang MT, Lin CT, Lin CW, Su MJ (2007) Apocynin alleviated hepatic oxidative burden and reduced liver injury in hypercholesterolaemia. Liver Int 27:529–537

    Article  CAS  PubMed  Google Scholar 

  29. Molgaard J, von Schenck H, Olsson AG (1989) Comparative effects of simvastatin and cholestyramine in treatment of patients with hypercholoesterolaemia. Eur J Clin Pharmacol 36:455–460

    Article  CAS  PubMed  Google Scholar 

  30. Mabuchi H, Nohara A, Kobayashi J, Kawashiri MA, Katsuda S, Inazu A, Koizumi J, Hokuriku Lipid Research Group (2007) Effects of CoQ10 supplementation on plasma lipoprotein lipid, CoQ10 and liver and muscle enzyme levels in hypercholesterolemic patients treated with atorvastatin: a randomized double-blind study. Atherosclerosis 195:182–189

    Article  Google Scholar 

  31. Arafa HM (2005) Curcumin attenuates diet-induced hypercholesterolemia in rats. Med Sci Monit 11:BR228–BR234

    Google Scholar 

  32. Hatzitolios A, Savopoulos C, Lazaraki G, Sidiropoulos I, Haritanti P, Lefkopoulos A, Karagiannopoulou G, Tzioufa V, Dimitrios K (2004) Efficacy of omega-3 fatty acids, atorvastatin and orlistat in non-alcoholic fatty liver disease with dyslipidemia. Indian J Gastroenterol 23:131–134

    PubMed  Google Scholar 

  33. Ekam VS, Ebong PE (2007) Serum protein and enzyme levels in rats following administration of antioxidant vitamins during caffeinated and non-caffeinated paracetamol induced hepatotoxicity. Niger J Physiol Sci 22:65–68

    CAS  PubMed  Google Scholar 

  34. Koyuturk M, Yanardag R, Bolkent S, Tunali S (2007) The potential role of combined anti-oxidants against cadmium toxicity on liver of rats. Toxicol Ind Health 23:393–401

    Article  CAS  PubMed  Google Scholar 

  35. Hamden K, Boujbiha MA, Masmoudi H, Ayadi FM, Jamoussi K, Elfeki A (2009) Combined vitamins (C and E) and insulin improve oxidative stress and pancreatic and hepatic injury in alloxan diabetic rats. Biomed Pharmacother 63:95–99

    Article  CAS  PubMed  Google Scholar 

  36. Ravel R (1995) Liver and biliary tract tests. In: Clinical Laboratory Medicine, 6th edn. Mosby-Year Book Inc., St. Louis, MO, pp 309–330

  37. Ramírez-Farías C, Madrigal-Santillán E, Gutiérrez-Salinas J, Rodríguez-Sánchez N, Martínez-Cruz M, Valle-Jones I, Gramlich-Martínez I, Hernández-Ceruelos A, Morales-Gonzaléz JA (2008) Protective effect of some vitamins against the toxic action of ethanol on liver regeneration induced by partial hepatectomy in rats. World J Gastroenterol 14:899–907

    Article  PubMed  Google Scholar 

  38. Ravel R (1995) Renal function tests. In: Clinical Laboratory Medicine, 6th edn. Mosby-Year Book Inc., St. Louis, MO, pp 166–177

Download references

Acknowledgments

This work was supported by a grant from the Heart and Stroke Foundation of Saskatchewan, Canada. The technical assistance of Ms. Barbara Raney and Mr. P. K. Chattopadhyay for this study is highly appreciated.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kailash Prasad.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Prasad, K. Effects of vitamin E on serum enzymes and electrolytes in hypercholesterolemia. Mol Cell Biochem 335, 67–74 (2010). https://doi.org/10.1007/s11010-009-0243-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-009-0243-x

Keywords

Navigation